What does CUSIP 44486Q111 represent in this 13F holders report?

CUSIP 44486Q111 is the security identifier for HUMAW - Humacyte, Inc. - *W EXP 08/27/202 used to aggregate holder disclosures.

How many institutions held HUMAW - Humacyte, Inc. - *W EXP 08/27/202 in Q1 2024?

6 institutional investors reported HUMAW - Humacyte, Inc. - *W EXP 08/27/202 for Q1 2024. Use the holders table for investor-level position and value details.

202 (HUMAW)

CUSIP: 44486Q111

Q1 2024 13F Holders as of 31 Mar 2024

Security type / class: Equity / *W EXP 08/27/202
Total 13F shares: 638,738
Total 13F value: $384,268
Share change: -160,970
SEC-reported price per share: $0.60
Number of holders: 6
Value change: -$22,697
Number of buys: 3
Number of sells: 5

Security key

44486Q111

Report period

Q1 2024

Institutions

Top holders

HUMAW full security history Ownership snapshot Full 13F holder table Humacyte, Inc. SEC filings Humacyte, Inc. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Ownership snapshot

Top reported holders of HUMAW - Humacyte, Inc. - *W EXP 08/27/202 (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader

Ayabudge LLC

Disclosed value leader

FRESENIUS MEDICAL CARE HO...

Comparable rows

0/15

Latest evidence

31 Dec 2023

3/4/5 13F Highest disclosed value: $21,792,154 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

FRESENIUS MEDICAL CARE HOLDINGS INC /NY/ has the largest disclosed position value at $21.79M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens FRESENIUS MEDICAL CARE HOLDINGS INC /NY/'s linked filing trail.

Disclosed position value Top 5

Ayabudge LLC $9.75M

FRESENIUS MEDICAL CARE HOLDINGS I... $21.79M

BlackRock Finance, Inc. $13.91M

VANGUARD GROUP INC $8.87M

GEODE CAPITAL MANAGEMENT, LLC $3.77M

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
Ayabudge LLC	3/4/5 10%+ Owner 3/4/5	— denominator unverified	$9,747,457 8,191,140 shares	—	17 Aug 2023
FRESENIUS MEDICAL CARE HOLDINGS INC /NY/	3/4/5 Former 10% Shareholder 3/4/5	— denominator unverified	$21,792,154 18,312,735 shares	—	26 Aug 2021
BlackRock Finance, Inc.	13F Company 13F	— denominator unverified	$13,913,980 4,899,289 shares	—	31 Dec 2023
VANGUARD GROUP INC	13F Company 13F	— denominator unverified	$8,870,075 3,123,266 shares	—	31 Dec 2023
GEODE CAPITAL MANAGEMENT, LLC	13F Company 13F	— denominator unverified	$3,765,333 1,325,675 shares	—	31 Dec 2023
MILLENNIUM MANAGEMENT LLC	13F Company 13F	— denominator unverified	$3,678,839 1,295,366 shares	—	31 Dec 2023

How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q1 2024

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

638,738

Rows available

Investor	Option	Weight %	Change %	SEC-reported value	* Price	Shares	Share Change	Activity	Report Period

^* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q1 2024 vs Q1 2024 Across Filers

Q1 2024 holders

Holder diff

Investor	Q1 2024 Shares	Q1 2024 Shares	Share Diff	Share Chg %	Q1 2024 value	Q1 2024 value	Value change	Value Chg %